Get my own profile
Public access
View all74 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Angela ReynoldsBio-TechneVerified email at bio-techne.com
- Julia AltermanUniversity of Massachusetts Medical SchoolVerified email at umassmed.edu
- Matthew HasslerUmass Medical SchoolVerified email at mail.mcgill.ca
- Dimas EcheverriaAssoc Director of Nucleic Acid Chemistry Center, UMass Medical SchoolVerified email at umassmed.edu
- Réka Haraszti MD PhDUniversitätsklinikum TübingenVerified email at med.uni-tuebingen.de
- William (Wes) SalomonTessera TherapeuticsVerified email at tesseratx.com
- Andrew ColesUniversity of Massachusetts Medical schoolVerified email at umassmed.edu
- Bruno M.D.C. GodinhoAtalanta TherapeuticsVerified email at atalantatx.com
- Marie DidiotUniversity of Massachusetts Medical SchoolVerified email at umassmed.edu
- Yuriy FedorovCase Western Reserve UniversityVerified email at case.edu
- Annabelle BiscansAstraZeneca R&D, SwedenVerified email at astrazeneca.com
- Maire F. OsbornRNA Therapeutics Institute | Univ. of Massachusetts Medical SchoolVerified email at umassmed.edu
- Amanda BirminghamSenior Bioinformatics Programmer; University of California, San DiegoVerified email at ucsd.edu
- Jonathan K. WattsProfessor, RNA Therapeutics Institute, UMass Chan Medical SchoolVerified email at umassmed.edu
- Annaleen VermeulenPrincipal Scientist, Horizon DiscoveryVerified email at horizondiscovery.com
- Socheata LySenior Scientist, ReNAgade TherapeuticsVerified email at renagadetx.com
- Mehran NikanResearch Fellow, Ionis PharmaceuticalsVerified email at ionisph.com
- Loic RouxNATAVerified email at natahub.org
- alexey wolfsonAdvirnaVerified email at advirna.com
- Melissa J. MooreModerna Therapeutics/UMass Medical SchoolVerified email at umassmed.edu